In addition, TOX-specific antibodies identified the malignant CD4+ T cells in the dermis and epidermis of CTCL, and in purified primary CTCL cells and in cultured cell lines. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.